537 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Acquired by Kohmann Bosshard Financial Services LLC

Kohmann Bosshard Financial Services LLC bought a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 537 shares of the medical instruments supplier’s stock, valued at approximately $52,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Barclays PLC raised its holdings in shares of Merit Medical Systems by 305.4% in the 3rd quarter. Barclays PLC now owns 112,727 shares of the medical instruments supplier’s stock worth $11,142,000 after purchasing an additional 84,923 shares in the last quarter. EULAV Asset Management increased its position in shares of Merit Medical Systems by 400.0% in the fourth quarter. EULAV Asset Management now owns 115,000 shares of the medical instruments supplier’s stock worth $11,123,000 after acquiring an additional 92,000 shares in the last quarter. Van ECK Associates Corp purchased a new position in shares of Merit Medical Systems in the third quarter worth approximately $718,000. Fisher Asset Management LLC increased its position in shares of Merit Medical Systems by 3.2% in the third quarter. Fisher Asset Management LLC now owns 221,690 shares of the medical instruments supplier’s stock worth $21,910,000 after acquiring an additional 6,837 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Merit Medical Systems by 85.6% in the third quarter. JPMorgan Chase & Co. now owns 575,946 shares of the medical instruments supplier’s stock worth $56,921,000 after acquiring an additional 265,648 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Stock Performance

Shares of MMSI opened at $103.03 on Tuesday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.82 and a current ratio of 5.36. The company has a market capitalization of $6.06 billion, a PE ratio of 50.51, a PEG ratio of 2.34 and a beta of 0.87. Merit Medical Systems, Inc. has a 52 week low of $70.70 and a 52 week high of $111.45. The company’s 50 day moving average price is $103.02 and its 200 day moving average price is $100.18.

Insiders Place Their Bets

In other Merit Medical Systems news, insider Brian G. Lloyd sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $99.50, for a total value of $2,487,500.00. Following the completion of the sale, the insider now directly owns 38,993 shares of the company’s stock, valued at $3,879,803.50. The trade was a 39.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Raul Jr. Parra sold 12,451 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $98.81, for a total transaction of $1,230,283.31. Following the completion of the sale, the chief financial officer now directly owns 24,201 shares of the company’s stock, valued at $2,391,300.81. This represents a 33.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.70% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Raymond James lifted their target price on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. Piper Sandler reissued an “overweight” rating and issued a $116.00 target price (up from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Barrington Research dropped their target price on shares of Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 26th. Needham & Company LLC dropped their target price on shares of Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating on the stock in a research report on Wednesday, February 26th. Finally, Canaccord Genuity Group lowered their price objective on shares of Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating on the stock in a research report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $110.78.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.